Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Providing essential cancer care to rural communities

2.

CAR T cells improve patients' quality of life: a study

3.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

4.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

5.

Severe obesity associated with reduced prevalence of recommended cancer screenings


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot